WILMINGTON, Del., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (PRLD), a clinical-stage precision oncology company, today reported financial results for the second quarter ended ...

First-in-class IV SMARCA2 degrader and potentially best-in-class CDK9 inhibitor on track to generate potential proof-of-concept data in 2024 Highly selective oral SMARCA2 degrader PRT7732 IND expected ...

Multi-year collaboration to jointly discover, develop, and commercialize novel oncology medicines for up to five programs, with the first ADC program focusing on a SMARCA degrader WILMINGTON, Del. & ...

This prototype isn't too far from a production version, from the looks of it Honda has presented an electric Prelude concept at the 2023 Japan Mobility Show in Tokyo. It’s a prototype not to far from ...

The Japan Mobility Show 2023 was an absolute hoot this year, showcasing a treasure trove of captivating concepts. Among the stars of the show was the revival of the Honda Prelude, a nearly ...

Developer Pracy Studios announced the story-driven rhythm RPG, Nocturne, will launch for the Nintendo Switch and Windows PC in 2023. The developer has released a free prelude chapter, Nocturne: ...

WILMINGTON, Del., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Nasdaq: PRLD), a clinical-stage precision oncology company, today reported its financial results for the fiscal ...

Prelude Therapeutics and AbCellera Enter Partnership to Develop First-in-Class Precision Antibody Drug Conjugates in Oncology Multi-year collaboration to jointly discover, develop, and commercialize ...